REPOTRECTINIB vs RESMETIROM: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
REPOTRECTINIB vs RESMETIROM: Safety Overview
| Metric | REPOTRECTINIB | RESMETIROM |
|---|---|---|
| Total FAERS Reports | 187 | 881 |
| Deaths Reported | 27 | 26 |
| Death Rate | 14.4% | 3.0% |
| Hospitalizations | 48 | 50 |
| Average Patient Age | 60.8 yrs | 58.1 yrs |
| % Female Patients | 61.1% | 65.3% |
| FDA Approval Date | Jun 11, 2024 | Mar 14, 2024 |
| Manufacturer | E.R. Squibb & Sons, L.L.C. | Madrigal Pharmaceuticals, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |